| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
18,703 |
16,994 |
$514K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
4,571 |
4,081 |
$169K |
| 99308 |
Subsequent nursing facility care, per day, straightforward |
1,321 |
823 |
$7K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
406 |
215 |
$4K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
796 |
734 |
$3K |
| 99309 |
Subsequent nursing facility care, per day, low to moderate complexity |
370 |
330 |
$3K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
71 |
55 |
$3K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
79 |
66 |
$2K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
133 |
120 |
$1K |
| 99307 |
|
112 |
87 |
$566.20 |
| 99406 |
|
109 |
90 |
$472.33 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
52 |
45 |
$468.64 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
1,926 |
1,612 |
$177.36 |
| 99318 |
|
12 |
12 |
$170.83 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
13 |
12 |
$126.88 |
| 99407 |
|
16 |
14 |
$61.16 |
| 90656 |
|
13 |
12 |
$37.20 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
29 |
26 |
$25.60 |
| G8754 |
Most recent diastolic blood pressure < 90 mmhg |
837 |
707 |
$0.00 |
| 1036F |
|
784 |
646 |
$0.00 |
| 1034F |
|
32 |
26 |
$0.00 |
| G8752 |
Most recent systolic blood pressure < 140 mmhg |
763 |
645 |
$0.00 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
69 |
67 |
$0.00 |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
19 |
17 |
$0.00 |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
149 |
140 |
$0.00 |
| 90633 |
|
12 |
12 |
$0.00 |
| 1159F |
|
13 |
13 |
$0.00 |